![]() Biotest Biotest is a company that specializes in the fields of clinical immunology, haematology as well as intensive care and emergency medicine. | ![]() Abeona Therapeutics Abeona Therapeutics is focusing on developing innovative therapies, including gene therapies, for rare diseases, including Sanfilippo Syndrome. | ||
Founding Date | Founding Date 1904 | Founding Date 1946 | Founding Date 2013 |
Type | Type Subsidiary | Type Public | Type Public |
Tags | |||
Locations | Locations King of Prussia, US HQ Broadmeadows, AU Parkville, AU Parkville, AU Wien, AT Mechelen, BE see more | Locations Dreieich, DE HQ | Locations Dallas, US HQ Madrid, ES Cleveland, US New York, US |
Employees | Employees 7,5692% decrease | Employees 2,4265% increase | Employees 5737% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 1.5 b | Valuation ($) 284.6 m |
Financial | |||
Revenue (est.) | Revenue (est.) $7.9b (FY, 2020) | Revenue (est.) €648.9m (FY, 2025) | Revenue (est.) $5.8m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods €540.5m (FY, 2025) | Cost of goods $1.5m (FY, 2025) |
Gross profit | Gross profit $4.5b (FY, 2020) | Gross profit €142.7m (FY, 2025) | Gross profit $4.3m (FY, 2025) |
Net income | Net income N/A | Net income (€70.7m) (FY, 2025) | Net income $71.2m (FY, 2025) |

Biotest is a company that specializes in the fields of clinical immunology, haematology as well as intensive care and emergency medicine.
View company
Abeona Therapeutics is focusing on developing innovative therapies, including gene therapies, for rare diseases, including Sanfilippo Syndrome.
View company